SHP2 inhibitor specifically suppresses the stemness of KRAS-mutant non-small cell lung cancer cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SHP2 inhibitor specifically suppresses the stemness of KRAS-mutant non-small cell lung cancer cells
Authors
Keywords
-
Journal
Artificial Cells Nanomedicine and Biotechnology
Volume 47, Issue 1, Pages 3231-3238
Publisher
Informa UK Limited
Online
2019-08-02
DOI
10.1080/21691401.2019.1646748
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors
- (2019) Tamer A. Ahmed et al. Cell Reports
- Excitatory neuron–specific SHP2-ERK signaling network regulates synaptic plasticity and memory
- (2019) Hyun-Hee Ryu et al. Science Signaling
- Src and SHP2 coordinately regulate the dynamics and organization of vimentin filaments during cell migration
- (2019) Cheng-Yi Yang et al. ONCOGENE
- Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells
- (2019) Lufeng Zheng et al. Journal of Hematology & Oncology
- SHP2 inhibition overcomes RTK-mediated pathway re-activation in KRAS mutant tumors treated with MEK inhibitors
- (2019) Hengyu Lu et al. MOLECULAR CANCER THERAPEUTICS
- Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling
- (2019) Eunhee Choi et al. Nature Communications
- MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression
- (2018) Zhen Cai et al. ARCHIVES OF ORAL BIOLOGY
- STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling
- (2018) Lufeng Zheng et al. Journal of Hematology & Oncology
- SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo
- (2018) Sara Mainardi et al. NATURE MEDICINE
- SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors
- (2018) Leila Dardaei et al. NATURE MEDICINE
- Myeloid-restricted ablation of Shp2 restrains melanoma growth by amplifying the reciprocal promotion of CXCL9 and IFN-γ production in tumor microenvironment
- (2018) P. Xiao et al. ONCOGENE
- IL22 Promotes Kras -Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties
- (2018) Nasim Khosravi et al. Cancer Immunology Research
- Status of KRAS in iPSCs Impacts upon Self-Renewal and Differentiation Propensity
- (2018) Kenji Kubara et al. Stem Cell Reports
- SHP2 protects endothelial cell barrier through suppressing VE-cadherin internalization regulated by MET-ARF1
- (2018) Jie Zhang et al. FASEB JOURNAL
- SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models
- (2018) Carmine Fedele et al. Cancer Discovery
- Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis
- (2018) Hua Zhao et al. ONCOGENE
- EGFR tyrosine kinase inhibitors versus chemotherapy as first-line therapy for non-small cell lung cancer patients with the L858R point mutation
- (2016) Jianlin Xu et al. Scientific Reports
- Lung cancer: Biology and treatment options
- (2015) Hassan Lemjabbar-Alaoui et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The mutational landscapes of genetic and chemical models of Kras-driven lung cancer
- (2014) Peter M. K. Westcott et al. NATURE
- Cancer Stemness in Apc- vs. Apc/KRAS-Driven Intestinal Tumorigenesis
- (2013) Mehrnaz Ghazvini et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search